Revestive 5 mg (Teduglutide KIT) 5 MG

REVESTIVE 5 MG is a subcutaneous medication used to manage specific gastrointestinal conditions. This kit contains 28 vials and pre-filled syringes for convenient administration.

Strength

5 MG

Pack Size

28X5MG VIALS & 28X0.5ML PFS

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REVESTIVE 5 MG, containing teduglutide, is generally used to support the healing and maintenance of the gastrointestinal tract. It is often prescribed for conditions that affect nutrient absorption and intestinal health. People may ask, 'What is REVESTIVE used for?' primarily in managing symptoms related to short bowel syndrome and other gastrointestinal disorders.

Side Effects

Common effects of REVESTIVE 5 MG may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild gastrointestinal discomfort. These effects are typically temporary and vary among individuals.

Precautions & Warnings

REVESTIVE 5 MG should be handled with care, ensuring proper storage and administration techniques. It is important to follow healthcare provider instructions for safe use. Always check for any signs of contamination before use.

Avoid Interactions

REVESTIVE 5 MG may interact with certain medications, particularly those metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

REVESTIVE 5 MG is used to support the healing and maintenance of the gastrointestinal tract, often in conditions like short bowel syndrome.

REVESTIVE 5 MG is administered subcutaneously using the provided pre-filled syringes. Follow the instructions provided by your healthcare provider.

Common side effects may include localized reactions at the injection site, such as redness or swelling, and mild gastrointestinal discomfort.

REVESTIVE 5 MG may interact with certain medications. Consult your healthcare provider to discuss potential interactions with your current medications.

REVESTIVE 5 MG should be stored as per the instructions provided, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.